{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:19:31Z","timestamp":1792815571422,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T00:00:00Z","timestamp":1487808000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Gerontol Geriat"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s00391-017-1198-2","type":"journal-article","created":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T11:07:53Z","timestamp":1487848073000},"page":"579-584","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Crystal arthritides \u2013 gout and calcium pyrophosphate arthritis","Kristall-Arthritiden \u2013 Gicht und Kalziumpyrophosphat-Arthritis"],"prefix":"10.1007","volume":"51","author":[{"given":"S.","family":"Schlee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. C.","family":"Bollheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Bertsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. C.","family":"Sieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"H\u00e4rle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,23]]},"reference":[{"key":"1198_CR1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1055\/s-0028-1109820","volume":"182","author":"A Artmann","year":"2010","unstructured":"Artmann A, Ratzenbock M, Noszian I et al (2010) Dual energy CT - a new perspective in the diagnosis of gout. Rofo 182:261\u2013266","journal-title":"Rofo"},{"key":"1198_CR2","first-page":"352","volume":"68","author":"KJ Bhansing","year":"2010","unstructured":"Bhansing KJ, Van Bon L, Janssen M et\u00a0al (2010) Gout: A\u00a0clinical syndrome illustrated and discussed. Neth J Med 68:352\u2013359","journal-title":"Neth J Med"},{"key":"1198_CR3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1759720X14542960","volume":"6","author":"PV Chowalloor","year":"2014","unstructured":"Chowalloor PV, Siew TK, Keen HI (2014) Imaging in gout: A review of the recent developments. Ther Adv Musculoskelet Dis 6:131\u2013143","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"1198_CR4","first-page":"257","volume":"69","author":"DB Crittenden","year":"2011","unstructured":"Crittenden DB, Pillinger MH (2011) The year in gout - 2010-2011. Bull NYU Hosp Jt Dis 69:257\u2013263","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"1198_CR5","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/art.27356","volume":"62","author":"N Dalbeth","year":"2010","unstructured":"Dalbeth N, Pool B, Gamble GD et\u00a0al (2010) Cellular characterization of the gouty tophus: A\u00a0quantitative analysis. Arthritis Rheum 62:1549\u20131556","journal-title":"Arthritis Rheum"},{"key":"1198_CR6","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1136\/annrheumdis-2014-205304","volume":"73","author":"N Dalbeth","year":"2014","unstructured":"Dalbeth N, Stamp L (2014) Hyperuricaemia and gout: Time for a\u00a0new staging system? Ann Rheum Dis 73:1598\u20131600","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 2","key":"1198_CR7","doi-asserted-by":"crossref","first-page":"ii2","DOI":"10.1093\/rheumatology\/kep086","volume":"48","author":"M Doherty","year":"2009","unstructured":"Doherty M (2009) New insights into the epidemiology of gout. Rheumatology (Oxford) 48(Suppl 2):ii2\u2013ii8","journal-title":"Rheumatology (Oxford)"},{"key":"1198_CR8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/acr.20344","volume":"63","author":"PC Grayson","year":"2011","unstructured":"Grayson PC, Kim SY, Lavalley M et al (2011) Hyperuricemia and incident hypertension: A\u00a0systematic review and meta-analysis. Arthritis Care Res (Hoboken) 63:102\u2013110","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1198_CR9","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/S0140-6736(06)68894-6","volume":"367","author":"P Harle","year":"2006","unstructured":"Harle P, Schlottmann K, Ehrenstein BP et\u00a0al (2006) A patient with arthritis, severe back pain, impaired wound healing, and perforated sigmoid colon. Lancet 367:2032","journal-title":"Lancet"},{"key":"1198_CR10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00002512-200724010-00002","volume":"24","author":"KT Hoskison","year":"2007","unstructured":"Hoskison KT, Wortmann RL (2007) Management of gout in older adults: Barriers to optimal control. Drugs Aging 24:21\u201336","journal-title":"Drugs Aging"},{"key":"1198_CR11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00003086-198804000-00023","volume":"229","author":"I Masuda","year":"1988","unstructured":"Masuda I, Ishikawa K (1988) Clinical features of pseudogout attack. A survey of 50 cases. Clin Orthop Relat Res 229:173\u2013181","journal-title":"Clin Orthop Relat Res"},{"key":"1198_CR12","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","volume":"74","author":"T Neogi","year":"2015","unstructured":"Neogi T, Jansen TL, Dalbeth N et\u00a0al (2015) 2015 gout classification criteria: An american college of rheumatology\/european league against rheumatism collaborative initiative. Ann Rheum Dis 74:1789\u20131798","journal-title":"Ann Rheum Dis"},{"key":"1198_CR13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2147\/CIA.S5476","volume":"5","author":"MK Reinders","year":"2010","unstructured":"Reinders MK, Jansen TL (2010) Management of hyperuricemia in gout: Focus on febuxostat. Clin Interv Aging 5:7\u201318","journal-title":"Clin Interv Aging"},{"key":"1198_CR14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1757-1146-4-13","volume":"4","author":"E Roddy","year":"2011","unstructured":"Roddy E (2011) Revisiting the pathogenesis of podagra: Why does gout target the foot? J\u00a0Foot Ankle Res 4:13","journal-title":"J Foot Ankle Res"},{"key":"1198_CR15","doi-asserted-by":"crossref","first-page":"C584","DOI":"10.1152\/ajpcell.00600.2006","volume":"293","author":"YY Sautin","year":"2007","unstructured":"Sautin YY, Nakagawa T, Zharikov S et al (2007) Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative\/nitrosative stress. Am J Physiol Cell Physiol 293:C584\u2013C596","journal-title":"Am J Physiol Cell Physiol"},{"key":"1198_CR16","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1136\/ard.2010.128454","volume":"69","author":"N Schlesinger","year":"2010","unstructured":"Schlesinger N, Thiele RG (2010) The pathogenesis of bone erosions in gouty arthritis. Ann Rheum Dis 69:1907\u20131912","journal-title":"Ann Rheum Dis"},{"key":"1198_CR17","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/qjmed\/hcr242","volume":"105","author":"E Suresh","year":"2012","unstructured":"Suresh E, Das P (2012) Recent advances in management of gout. QJM 105:407\u2013417","journal-title":"QJM"},{"key":"1198_CR18","first-page":"U749","volume":"117","author":"D Townshend","year":"2004","unstructured":"Townshend D, Pai V (2004) Gouty tenosynovitis - more common than we think? N\u00a0Z Med\u00a0J 117:U749","journal-title":"N Z Med J"},{"key":"1198_CR19","first-page":"253","volume":"63","author":"F Viazzi","year":"2011","unstructured":"Viazzi F, Leoncini G, Pontremoli R (2011) Cardiovascular and renal effects of hyperuricaemia and gout. Reumatismo 63:253\u2013262","journal-title":"Reumatismo"},{"key":"1198_CR20","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/ard.2010.139105","volume":"70","author":"W Zhang","year":"2011","unstructured":"Zhang W, Doherty M, Bardin T et\u00a0al (2011) European league against rheumatism recommendations for calcium pyrophosphate deposition. Part I: Terminology and diagnosis. Ann Rheum Dis 70:563\u2013570","journal-title":"Ann Rheum Dis"}],"container-title":["Zeitschrift f\u00fcr Gerontologie und Geriatrie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00391-017-1198-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00391-017-1198-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00391-017-1198-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T17:00:52Z","timestamp":1658682052000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00391-017-1198-2"}},"subtitle":["Part\u00a02: clinical features, diagnosis and differential diagnostics","Teil\u00a02: Klinische Merkmale, Diagnostik und Differenzialdiagnose"],"short-title":[],"issued":{"date-parts":[[2017,2,23]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["1198"],"URL":"https:\/\/doi.org\/10.1007\/s00391-017-1198-2","relation":{},"ISSN":["0948-6704","1435-1269"],"issn-type":[{"value":"0948-6704","type":"print"},{"value":"1435-1269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,23]]}}}